DEUTERATED COMPOUNDS AND USES THEREOF
    15.
    发明申请

    公开(公告)号:US20200297875A1

    公开(公告)日:2020-09-24

    申请号:US16895352

    申请日:2020-06-08

    Abstract: The present invention relates to deuterated and optionally detectably labeled compounds of formula (I) and formula (V): and salts thereof, wherein R1, R2, A, and X10-X19 have any of the values defined in the specification. Also included are pharmaceutical compositions comprising such compounds and salts, and methods of using such compounds and salts as imaging agents.

    DEUTERATED COMPOUNDS AND USES THEREOF
    17.
    发明申请
    DEUTERATED COMPOUNDS AND USES THEREOF 审中-公开
    去除化合物及其用途

    公开(公告)号:US20160250358A1

    公开(公告)日:2016-09-01

    申请号:US15006997

    申请日:2016-01-26

    CPC classification number: A61K51/0459 C07B59/002 C07B2200/05 C07D487/04

    Abstract: The present invention relates to deuterated and optionally detectably labeled compounds of formula (I) and formula (V): and salts thereof, wherein R1, R2, A, and X10-X19 have any of the values defined in the specification. Also included are pharmaceutical compositions comprising such compounds and salts, and methods of using such compounds and salts as imaging agents.

    Abstract translation: 本发明涉及氘化和任选可检测地标记的式(I)和式(Ⅴ)化合物及其盐,其中R1,R2,A和X10-X19具有说明书中定义的任何值。 还包括包含这些化合物和盐的药物组合物,以及使用这些化合物和盐作为成像剂的方法。

Patent Agency Ranking